Another explanation is that when tumor cells undergo EMT, the demand for iron increases, which is accompanied by a shift in the way cells absorbing iron, from TfR1-mediated transferrin to CD44-mediated hyaluronic acid-iron complex as the main approach (Figure 1). The gene discussed is TFRC; the disease is neoplasm.